The scientific basis for TFA regulations-Is it sufficient? Comments from the USA

Atherosclerosis Supplements

Volumn 7, Issue 2, 2006, Pages 69-71

  Willett, W C ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Blood lipids; Coronary heart disease; FDA; Regulations; Trans fatty acids

Indexed keywords

FOOD ADDITIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANS FATTY ACID;

ARTICLE; BLOOD; CATERING SERVICE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FAT INTAKE; FOOD AND DRUG ADMINISTRATION; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED STATES;

BIOLOGICAL MARKERS; CORONARY DISEASE; DIETARY FATS, UNSATURATED; FOOD INDUSTRY; HUMANS; INFLAMMATION; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; TRANS FATTY ACIDS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33744816774     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosissup.2006.04.016     Document Type: Article

References (2)

1. Ascherio A., Katan M.B., Zock P.L., Stampfer M.J., and Willett W.C. Trans fatty acids and coronary heart disease. N Engl J Med 340 (1999) 1994-1998
2. Willett W. Trans fatty acids and cardiovascular disease-epidemiological data [Article no. 2 in this journal].